Tuesday, July 21, 2015

Health Highlights: July 24, 2014


Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

CDC Resumes Transfer of Biological Samples Between Labs

The U.S. Centers for Disease Control and Prevention said Thursday that it would allow the first transfer between its labs of potentially hazardous biological material since a ban on such shipments was put in place earlier this month.

The ban followed revelations of recent incidents involving mishandling of potentially dangerous samples of anthrax, botulism bacteria and the H5N1 flu virus, the Washington Post reported.

So far, resumption of sample transfers is only happening at the CDC's tuberculosis laboratory, and involves the movement of inactivated TB bacteria to lower-level CDC labs for DNA analysis, according to an agency statement. The ban is still in place at the agency's other laboratories, pending a safety review, according to CDC spokesman Tom Skinner.

In addition, the CDC has also appointed an 11-member external laboratory safety group to advise CDC officials on what safety improvements are needed at agency labs, the Post reported.

On Tuesday, the director of the CDC laboratory implicated in the anthrax incident, Michael Farrell, tendered his resignation, Skinner announced.

Copyright © 2014 HealthDay. All rights reserved.
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
Latest Health Videos
Also on Philly.com:
letter icon Newsletter